Ocular Therapeutix eye drug meets goal in late-stage study

Ocular Therapeutix says its OTX-DP reduced pain and inflammation after cataract surgery in a late-stage study of the drug-device combination.

Ocular Therapeutix Inc.

News Well, Clinical Trials, Optical/Ophthalmic

read more

from MassDevice - FDA and Medical device business news and jobs for the medical device industry http://ift.tt/1C45YWo